Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Mitochondrial diabetes mellitus

A Rötig1, J P Bonnefont, A Munnich

  • 1Unité de Recherches sur les Handicaps Génétiques de l'Enfant, INSERM 393, Hôpital des Enfants Malades, Paris, France.

Diabetes & Metabolism
|October 1, 1996
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Evidence of autosomal dominant Leber congenital amaurosis (LCA) underlain by a CRX heterozygous null allele.

Journal of medical genetics·2003
Same author

Spectrum of NSD1 mutations in Sotos and Weaver syndromes.

Journal of medical genetics·2003
Same author

[Preimplantation genetic diagnosis and its psychological effects].

Journal de gynecologie, obstetrique et biologie de la reproduction·2003
Same author

Homozygosity mapping of a Desbuquois dysplasia locus to chromosome 17q25.3.

Journal of medical genetics·2003
Same author

Cryptic terminal deletion of chromosome 9q34: a novel cause of syndromic obesity in childhood?

Journal of medical genetics·2003
Same author

Prenatal diagnosis of spinal muscular atrophy by genetic analysis of circulating fetal cells.

Lancet (London, England)·2003
Same journal

Glucagon-like peptide-1 receptor agonists and risk of pancreaticobiliary cancers in patients with type 2 diabetes: a nationwide cohort study.

Diabetes & metabolism·2026
Same journal

Decreased risk of new-onset osteoporosis in patients with Type 2 diabetes on SGLT-2 inhibitors.

Diabetes & metabolism·2026
Same journal

Two faces of autoimmune hyperinsulinemia: contrasting type B insulin resistance syndrome and exogenous insulin antibody syndrome.

Diabetes & metabolism·2026
Same journal

CGM-based metrics and mortality in older adults living with type 2 diabetes on insulin therapy: a secondary analysis of the HYPOAGE study.

Diabetes & metabolism·2026
Same journal

Persistent burden and management gaps of hypoglycemia in pediatric type 1 diabetes: insights from the Epi-GLUREDIA Study.

Diabetes & metabolism·2026
Same journal

Blood oxygen saturation and its associations with autonomic and peripheral neuropathy in diabetes.

Diabetes & metabolism·2026
See all related articles

Mitochondrial DNA mutations are linked to diabetes mellitus, often presenting with other symptoms like deafness or organ failure. This review examines these mitochondrial diabetes mellitus abnormalities and their prevalence.

Area of Science:

  • Genetics
  • Endocrinology
  • Molecular Biology

Background:

  • Mitochondrial DNA (mtDNA) mutations and deletions are increasingly associated with human diseases.
  • Mitochondrial disorders can manifest with non-neuromuscular symptoms, including diabetes mellitus.
  • Diabetes mellitus is linked to large mtDNA rearrangements and point mutations, particularly in tRNA genes.

Purpose of the Study:

  • To review different types of mtDNA abnormalities associated with diabetes.
  • To study the prevalence of mitochondrial diabetes mellitus.
  • To highlight the clinical features of mitochondrial diabetes, including its association with other symptoms.

Main Methods:

  • Literature review of genetic studies on mtDNA abnormalities and diabetes.
  • Analysis of reported cases of mitochondrial diabetes mellitus.

Related Experiment Videos

  • Prevalence study of mitochondrial diabetes.

    • Main Results:

    • Various mtDNA abnormalities, including deletions and point mutations in tRNA genes, are associated with diabetes mellitus.
    • Mitochondrial diabetes frequently co-occurs with other clinical symptoms such as deafness, neurological disorders, cardiac, and renal failure.
    • The paper reviews the spectrum of mtDNA defects implicated in diabetes and assesses the prevalence of this condition.

    Conclusions:

    • Mitochondrial DNA abnormalities are a significant factor in the development of diabetes mellitus.
    • Mitochondrial diabetes is characterized by a high incidence of associated systemic symptoms.
    • Further research into mtDNA defects is crucial for understanding and managing mitochondrial diabetes mellitus.